Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.28M Sell
4,200
-900
-18% -$463K ﹤0.01% 3713
2026
Q1
$2.21M Sell
5,100
-9,400
-65% -$4.14M ﹤0.01% 3777
2025
Q4
$4.76M Buy
14,500
+1,800
+14% +$579K ﹤0.01% 3067
2025
Q3
$4.06M Buy
12,700
+4,100
+48% +$1.13M ﹤0.01% 3354
2025
Q2
$2.37M Buy
8,600
+1,700
+25% +$346K ﹤0.01% 3731
2025
Q1
$1.27M Buy
6,900
+100
+1% +$23.1K ﹤0.01% 4169
2024
Q4
$1.34M Buy
6,800
+5,000
+278% +$961K ﹤0.01% 3960
2024
Q3
$375K Sell
1,800
-200
-10% -$42.7K ﹤0.01% 5049
2024
Q2
$469K Buy
+2,000
New +$396K ﹤0.01% 4635

Other funds holding NVMI

Israel Englander's NVMI Position: Q2 2026 in Review

Israel Englander increased its Nova (NVMI) stake by 2.2% in Q2 2026, buying an estimated $38.5K and bringing the position to 3,414 shares worth $1.85M. The position accounts for ﹤0.01% of the portfolio, ranked #3881.

Israel Englander first reported a position in NVMI in Q4 2013 and has held it in 34 quarters since. The position peaked at $92.7M in Q3 2024. 342 funds tracked by Wall St. Rank hold NVMI as of Q2 2026.

  • Israel Englander held 3,414 shares of Nova worth $1.85M as of Q2 2026.
  • Israel Englander bought 75 Nova shares in Q2 2026, an estimated $38.5K.
  • Nova made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #3881 holding.
  • Israel Englander first reported a position in Nova in Q4 2013 and has held it in 34 quarters since.
  • Israel Englander's Nova position peaked at $92.7M in Q3 2024.
  • 342 funds tracked by Wall St. Rank held Nova as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.